|
Gene Therapy
Citations 31-40 of 434 total displayed.
|
Past content
(since Aug 1998):
|
A novel in vivo siRNA delivery system specifically targeting dendritic cells and silencing CD40 genes for immunomodulation
- Xiufen Zheng, Costin Vladau, Xusheng Zhang, Motohiko Suzuki, Thomas E. Ichim, Zhu-Xu Zhang, Mu Li, Ewa Carrier, Bertha Garcia, Anthony M. Jevnikar, and Wei-Ping Min
Blood 2009; 113: 2646-2654.
[Abstract]
[Full text]
[PDF]
Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell–mediated gene therapy
- Pablo Laje, Dezhi Shang, Wenjing Cao, Masami Niiya, Masayuki Endo, Antoneta Radu, Nicole DeRogatis, Friedrich Scheiflinger, Philip W. Zoltick, Alan W. Flake, and X. Long Zheng
Blood 2009; 113: 2172-2180.
[Abstract]
[Full text]
[PDF]
Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1
- Robert C. Carlisle, Ying Di, Anna M. Cerny, Andreas F.-P. Sonnen, Robert B. Sim, Nicola K. Green, Vladimir Subr, Karel Ulbrich, Robert J. C. Gilbert, Kerry D. Fisher, Robert W. Finberg, and Leonard W. Seymour
Blood 2009; 113: 1909-1918.
[Abstract]
[Full text]
[PDF]
Peripheral blood lymphocytes genetically modified to express the self/tumor antigen MAGE-A3 induce antitumor immune responses in cancer patients
- Raffaella Fontana, Marco Bregni, Arcadi Cipponi, Laura Raccosta, Cristina Rainelli, Daniela Maggioni, Francesca Lunghi, Fabio Ciceri, Sylvain Mukenge, Claudio Doglioni, Didier Colau, Pierre G. Coulie, Claudio Bordignon, Catia Traversari, and Vincenzo Russo
Blood 2009; 113: 1651-1660.
[Abstract]
[Full text]
[PDF]
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes.
- Xin M. Luo, Emily Maarschalk, Ryan M. O'Connell, Pin Wang, Lili Yang, and David Baltimore
Blood 2009; 113: 1422-1431.
[Abstract]
[Full text]
[PDF]
Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation
- Robert R. Jenq, Christopher G. King, Christine Volk, David Suh, Odette M. Smith, Uttam K. Rao, Nury L. Yim, Amanda M. Holland, Sydney X. Lu, Johannes L. Zakrzewski, Gabrielle L. Goldberg, Adi Diab, Onder Alpdogan, Olaf Penack, Il-Kang Na, Lucy W. Kappel, Jedd D. Wolchok, Alan N. Houghton, Miguel-Angel Perales, and Marcel R. M. van den Brink
Blood 2009; 113: 1574-1580.
[Abstract]
[Full text]
[PDF]
Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy
- Glenn P. Niemeyer, Roland W. Herzog, Jane Mount, Valder R. Arruda, D. Michael Tillson, John Hathcock, Frederik W. van Ginkel, Katherine A. High, and Clinton D. Lothrop, Jr
Blood 2009; 113: 797-806.
[Abstract]
[Full text]
[PDF]
Silencing of T lymphocytes by antigen-driven programmed death in recombinant adeno-associated virus vector–mediated gene therapy
- Victoria M. Velazquez, David G. Bowen, and Christopher M. Walker
Blood 2009; 113: 538-545.
[Abstract]
[Full text]
[PDF]
Enhancement of DNA tumor vaccine efficacy by gene gun–mediated codelivery of threshold amounts of plasmid-encoded helper antigen
- Wolfgang W. Leitner, Matthew C. Baker, Thomas L. Berenberg, Michael C. Lu, P. Josef Yannie, and Mark C. Udey
Blood 2009; 113: 37-45.
[Abstract]
[Full text]
[PDF]
Stable transduction of quiescent T cells without induction of cycle progression by a novel lentiviral vector pseudotyped with measles virus glycoproteins
- Cecilia Frecha, Caroline Costa, Didier Nègre, Emmanuel Gauthier, Stephen J. Russell, François-Loïc Cosset, and Els Verhoeyen
Blood 2008; 112: 4843-4852.
[Abstract]
[Full text]
[PDF]
|
|
